當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

 >  文獻(xiàn)檢索 

DrugsoftheFuture（DOF）2020年5-7期 文獻(xiàn)必須完整、準(zhǔn)確   [更多]

需求幾十篇文獻(xiàn) 1.Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer 2、J Clin Gastroenterol. 2016 Jan;50(1):e1-7. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. Tan VP1, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. 3、Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Gut. 2018 Mar;67(3):430-440. 4、The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. Chen TS, Chang FY. J Clin Gastroenterol. 2007 Oct;41(9):819-22. 5、 Circulation. 1998 Nov 24;98(21):2282-9. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Senni M1, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. 6、 Anesth Analg. 2018 Nov 9. doi: 10.1213/ANE.0000000000003887. [Epub ahead of print] Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. 7. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD 8.Macromolecules, 1983, 16 (8), pp 1367-1374DOI: 10.1021/ma00242a019 Publication Date: August 1983 ACS Legacy Archive 9、Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats Kai Zhang Zuowang Ma Weiding Wang Ruimeng Liu Yue Zhang Meng Yuan Guangping Li 10、Vascular. 2018 Dec;26(6):626-633. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia. 嚴(yán)重肢體缺血患者潰瘍愈合和無截肢生存的預(yù)后因素 Furuyama T, Onohara T, Yamashita S, Yoshiga R, Yoshiya K, Inoue K, Morisaki K, Kyuragi R, Matsumoto T, Maehara Y. 11、Curr Drug Discov Technol. 2018 Oct 8. Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.   [更多]

求DOF 2019年1-3期文獻(xiàn)   [更多]

每篇文獻(xiàn)完整，清晰   [更多]

需求葡萄糖2019年版英國藥典標(biāo)準(zhǔn)以及附錄   [更多]

鹽酸左布諾洛爾（Levobunolol Hydrochloride）原料藥質(zhì)量標(biāo)準(zhǔn)1、需要中國批準(zhǔn)的質(zhì)量標(biāo)準(zhǔn)2、不要、原研或外國的。   [更多]

正式藥典標(biāo)準(zhǔn)，不用PF版本   [更多]

具體要求; 需要英國藥典標(biāo)準(zhǔn)“Appendix XII B. Monographs of the British Pharmacopoeia”《 BP2017 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求購一個(gè)中文期刊帳號(hào)，要能長期使用，使用一年，維普、知網(wǎng)、萬方數(shù)據(jù)庫中其中一個(gè)都可以。不要那種VPN，要能直接訪問中文期刊數(shù)據(jù)庫，沒有流量限制。   [更多]

標(biāo)題：求購“L-Aspartic Acid“標(biāo)準(zhǔn) 詳細(xì)要求： 需求名稱：“L-Aspartic Acid 需求數(shù)量：三大藥典各一份 價(jià)格預(yù)算：200 要求時(shí)間：請(qǐng)?jiān)?018年10月22號(hào)之前   [更多]